B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MELANOCORTIN

MOLECULAR TARGET

melanocortin receptor 4 (human)

UniProt: P3224514 compounds

MELANOCORTIN (melanocortin receptor 4 (human)) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MELANOCORTIN

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alpha-MSH3.8144
2melanotan-II [Supplementary Concept] synthetic cyclic heptapeptide,1.393
3Chlorhexidine1.393
4Sertraline1.102
5Astemizole Antihistamine drug now withdrawn from1.102
6Tubercidin1.102
7palmidrol [Supplementary Concept]0.691
8Celecoxib0.691
9Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.0.691
10Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.0.691
11Digoxin0.691
12Hexachlorophene0.691
13Lanatosides Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale,0.691
14Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide.0.691

About MELANOCORTIN as a Drug Target

MELANOCORTIN (melanocortin receptor 4 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented MELANOCORTIN interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MELANOCORTIN inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.